CyclinD Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Which Cyclin forms active complexes with CDK4 and CDK6 during the G1 phase?

A

Cyclin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the function of Cyclin D-CDK4/6 complexes in the G1 phase?

A

They phosphorylate the retinoblastoma protein (Rb).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What effect does hypophosphorylated Rb have on E2F transcription factors?

A

It binds to them, preventing the initiation of gene transcription required for S phase entry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens to Rb when phosphorylated by Cyclin D-CDK4/6?

A

It becomes inactivated, releasing E2F.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of E2F after its release from Rb?

A

It promotes the transcription of genes necessary for DNA replication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What critical checkpoint must a cell pass to commit to entering the S phase?

A

The restriction point (R-Point).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which complexes are crucial for a cell to pass the restriction point in late G1?

A

Cyclin D-CDK4/6 complexes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What phase does the cell enter after passing the restriction point?

A

The S phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does phosphorylation affect the retinoblastoma protein (Rb)?

A

It inactivates Rb, allowing the cell cycle to progress.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the consequence of E2F being released from Rb in the cell cycle?

A

It initiates the transcription of genes required for DNA replication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What determines if a cell commits to DNA replication regardless of external signals?

A

Passing the restriction point (R-Point) in late G1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What prevents E2F from initiating S phase gene transcription when bound to it?

A

Hypophosphorylated retinoblastoma protein (Rb).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main function of Cyclin D in cell cycle regulation?

A

To partner with CDK4 and CDK6 to phosphorylate Rb, facilitating the G1/S transition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of Cyclin D-CDK4/6 complexes in the G1 phase?

A

They phosphorylate the retinoblastoma protein (Rb), promoting the G1/S transition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens to retinoblastoma protein (Rb) when phosphorylated by Cyclin D-CDK4/6?

A

It becomes inactivated, releasing E2F transcription factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the consequence of E2F release during the G1 phase?

A

E2F promotes the transcription of genes required for S phase entry.

17
Q

How does Rb protein regulate the G1/S transition before phosphorylation?

A

It binds to E2F, preventing transcription of S phase genes.

18
Q

What is the Restriction Point (R-Point) in the cell cycle?

A

A checkpoint in late G1 where the cell commits to entering the S phase.

19
Q

What is the significance of passing the Restriction Point in the G1 phase?

A

The cell commits to DNA replication, regardless of external signals.

20
Q

How do Cyclin D-CDK4/6 complexes influence the Restriction Point?

A

Their activity is crucial for passing the Restriction Point.

21
Q

What does hypophosphorylated Rb do?

A

Binds to E2F, inhibiting the transcription of genes required for S phase.

22
Q

What marks the commitment to the S phase?

A

The cell passing the Restriction Point.

23
Q

What phase of the cell cycle is regulated by Cyclin D-CDK4/6 activity?

A

The G1 phase.

24
Q

Which transcription factors are released upon Rb phosphorylation?

A

E2F transcription factors.

25
Q

Why is Cyclin D important in the cell cycle?

A

It partners with CDK4/6 to regulate the G1/S transition.

26
Q

What triggers the inactivation of Rb protein?

A

Phosphorylation by Cyclin D-CDK4/6 complexes.

27
Q

What is the clinical significance of dysregulation of Cyclin D in oncogenesis?

A

It leads to uncontrolled cell proliferation due to aberrant activation of CDK4/6, observed in various cancers.

28
Q

In which cancer is Cyclin D1 overexpression particularly associated?

A

Mantle cell lymphoma.

29
Q

What role does Cyclin D1 play in cancer development?

A

It acts as an oncogene, promoting tumorigenesis by overriding normal cell cycle controls.

30
Q

How is Cyclin D1 overexpression linked to breast cancer?

A

It contributes to tumorigenesis by driving cell proliferation.

31
Q

What is the therapeutic approach targeting Cyclin D-CDK4/6 complexes in cancer treatment?

A

Use of specific inhibitors like palbociclib, ribociclib, and abemaciclib.

32
Q

Which cancers are CDK4/6 inhibitors particularly effective against?

A

Hormone receptor-positive breast cancer.

33
Q

How do CDK4/6 inhibitors work?

A

They block the kinase activity of CDK4/6, leading to cell cycle arrest in G1 phase.

34
Q

Name a mechanism by which cancer cells develop resistance to CDK4/6 inhibitors.

A

Upregulation of Cyclin E-CDK2 activity.

35
Q

What is another mechanism of resistance to CDK4/6 inhibitors?

A

Loss of Rb function.

36
Q

How does overexpression of CDK6 contribute to resistance to CDK4/6 inhibitors?

A

It bypasses the inhibition and allows cell cycle progression.

37
Q

Why is Cyclin D1 overexpression a significant marker in esophageal cancer?

A

It indicates a higher likelihood of aggressive tumor behavior.

38
Q

What is a common outcome of gene amplification involving Cyclin D1 in cancers?

A

Increased cell cycle progression leading to tumor growth.

39
Q

How does chromosomal translocation involving Cyclin D1 affect cancer development?

A

It can result in abnormal Cyclin D1 expression, driving oncogenesis.